The Cognitive Science of Religion (Part 2) – Video

Posted on by


The Cognitive Science of Religion (Part 2)
For more on this event, visit: bit.ly For more on the Berkley Center, visit: berkleycenter.georgetown.edu May 3, 2011 | Is religious experience intrinsically related to human cognition? In recent decades this question has prompted significant academic interest from a wide range of scholarly disciplines including anthropology, biology, philosophy, and psychology. The result of this research is an emerging consensus among scientists that the mind has a natural bias towards religious ideas. The human inclination towards religion, if true, would have consequences for the treatment of religion in public affairs. Cognitive psychologist Justin Barrett has been a leading figure in the exploration of this question and spoke to Religious Freedom Project on May 4, 2011. Richard Sosis, a prominent scholar in the field of evolutionary anthropology offered a formal response. Following their interventions, a general discussion ensued between invited scholars representing a diverse set of academic fields.From:berkleycenterViews:1 0ratingsTime:49:14More inEducation

Go here to read the rest:
The Cognitive Science of Religion (Part 2) - Video

Multimodal Optical and Nuclear Imaging – Video

Posted on by


Multimodal Optical and Nuclear Imaging
Preclinical applications of biomedical imaging are rapidly expanding as tools for molecular biology research and diagnostic contrast agent development. As no single imaging modality can provide a full picture of the complex biology of disease, more researchers are turning to multimodality imaging. The availability of contrast agents for optical and nuclear imaging has never been higher, including both genetically engineered reporters and synthetic compounds. In this webinar, we will discuss the principles of planar optical imaging and scintigraphy in the context of imaging in animal models. These techniques are economical and simple, allowing facile data co-registration. We will review multimodal imaging strategies with respect to laboratory research and clinical applications.From:BrukerBioSpin PCIViews:0 0ratingsTime:36:39More inScience Technology

Continued here:
Multimodal Optical and Nuclear Imaging - Video

Is YouTube Making Us Smarter? | Idea Channel | PBS – Video

Posted on by


Is YouTube Making Us Smarter? | Idea Channel | PBS
Did you know there #39;s a place where you can learn just about anything you #39;d like? It #39;s true! It #39;s called YOU TUBE!!! Sure, YouTube has hundreds of thousands of hours of deliciously time-wasting content, but it #39;s a whole lot more than just a black hole of pet videos and FAIL clips. If you know where to go, YouTube has some of the best educational content on the planet! And although watching Kahn Academy all day might be a bit dry, the creativity of YouTube creators has allowed "education" to be transformed in variety of amazing and engaging ways. YouTube probably won #39;t replace schools anytime soon, but it #39;s a pretty rad alternative. So time to stop watching cat videos and get your learn on! Let us know what sorts of crazy ideas you have, about this episode and otherwise: Tweet at us! @pbsideachannel (yes, the longest twitter username ever) Email us! pbsideachannel [at] gmail [dot] com Hosted by Mike Rugnetta (@mikerugnetta) Made by Kornhaber Brown (www.kornhaberbrown.com) Youtube People Brady Haran Numberphile http://www.youtube.com Deep Sky Videoswww.youtube.com Vsauce http://www.youtube.com http://www.youtube.com http://www.youtube.com Smarter Everyday http://www.youtube.com ViHart http://www.youtube.com ASAP Science http://www.youtube.com CGPGrey http://www.youtube.com CrashCourse http://www.youtube.com MinutePhysics http://www.youtube.com Sci Show http://www.youtube.com Veritasium http://www.youtube.com Teachers with YouTube Channels Amor Sciendi http://www.youtube.com Bozeman Biology http://www.youtube.com Keith Hughes http://www.youtube.com More assets: ocw.mit.edu www ...From:pbsideachannelViews:2124 1158ratingsTime:08:04More inEducation

Read more here:
Is YouTube Making Us Smarter? | Idea Channel | PBS - Video

ATPtoADP – Video

Posted on by


ATPtoADP
A short explanation that resolves the seemly contradictory statements "breaking the high energy phosphate bond on ATP releases energy" (learned in biology classes), and "All bond breaking costs energy" (as taught in chemistry classes).From:kcousins47Views:0 0ratingsTime:02:53More inEducation

See the original post:
ATPtoADP - Video

Hyper-real Insect Design with Eric Keller – Video

Posted on by


Hyper-real Insect Design with Eric Keller
Hyper-real Insect Design with Eric Keller http://www.thegnomonworkshop.com In this DVD Eric Keller demonstrates his process for designing, modeling, and rendering an original photo realistic insect using ZBrush 4 R4, Photshop, Maya, and V-Ray. Eric talks about how he relies on insect physiology and evolutionary biology as guidelines for his original concept and how to bring photo reference directly into ZBrush using Spotlight. Eric takes the design from basic blockout using dynamesh all the way to completed model. Eric demonstrates the new topology tools of ZBrush 4 R 4 as well as how to generate UV texture coordinates. The model is brought into Maya and prepared for rendering. Eric discusses displacement and bump map set up in VRay, how to create custom materials, and how to set up the VRay Physical camera to create the look of macro photography.From:thegnomonworkshopViews:2 0ratingsTime:02:03More inEducation

See the rest here:
Hyper-real Insect Design with Eric Keller - Video

ZIOPHARM Oncology Presents Systemic, DNA/Cell Plasmid Therapy Showing Long-Term Persistence and Anti-Tumor Effects at …

Posted on by

NEW YORK, Nov. 7, 2012 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (ZIOP), a drug development company employing small molecule and synthetic biology approaches to cancer therapy, announced today results from a preclinical study demonstrating the long-term persistence and anti-tumor effects of a new synthetic biology approach (DNA/cell plasmid) to controlled protein production in vivo. This embedded controlled bioreactor study was presented at the EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics, taking place November 6-9 in Dublin, Ireland, and was conducted jointly by ZIOPHARM and Intrexon Corporation, a synthetic biology company that utilizes its proprietary technologies to provide control over cellular function, ZIOPHARM's exclusive channel partner for the development of DNA therapeutics.

"These data demonstrate the potential of our disruptive technologies, including UltraVector(R), RTS(R), and our cell engineering capabilities," said Samuel Broder, M.D., Chairman of Intrexon's Therapeutic Opportunities Committee and former Director of the NCI (National Cancer Institute). "By using tightly controlled, purpose-built, cellular protein factories, we open up therapeutic windows for a broad array of proteins. This study demonstrates the long-term persistence of this approach, with sustained protein production and therapeutic anti-tumor efficacy drawing from only a single intramuscular administration of plasmid DNA."

Hagop Youssoufian, M.D., President of Research and Development and Chief Medical Officer of ZIOPHARM, said, "These data are very exciting, as they provide us with another systemic approach for the delivery of therapeutic proteins to a target cancer using engineered DNA transgenes. We have already seen the potential in the clinic of delivering these transgenes using dendritic cells and viral vectors. Each approach gives us a means of optimizing the timing, concentration and location of therapeutic proteins; ultimately allowing us to dislocate cancer's signaling networks with minimal interference to our natural systems. We look forward to further our study of therapeutic anti-cancer proteins delivered via this revolutionary technology."

For this study, a RheoSwitch(R)-regulated (RTS(R)) interferon alpha (IFN) plasmid transgene was evaluated as a means of widening the therapeutic window of IFN in a melanoma mouse model. DNA vectors for the controlled expression of murine or human IFN were optimized using Intrexon's UltraVector(R) platform, then transfected into human fibrosarcoma cells or myoblasts, forming RTS-IFN plasmids. These plasmids were subsequently electroporated into the skeletal muscle of normal or melanoma tumor-bearing mice, and then activated using an oral activator ligand (AL).

A single intramuscular electroporation of RTS-IFN combined with daily oral activator ligand treatment led to significant tumor growth inhibition, comparable to chemotherapy or repeated bolus injection with recombinant mIFN protein, but without overt toxicity, as assessed by body weight change and survival. Treatment with pRTS-IFN resulted in sustained serum and tumor expression of mouse IFN for approximately 4 months (study termination), as well as expression of the angiogenic biomarker IP-10, and activation of T cells (CD4 and CD8), NK cells, and dendritic cells.

About ZIOPHARM Oncology, Inc.:

ZIOPHARM Oncology is a biopharmaceutical company focused on the development and commercialization of new cancer therapies. The Company's clinical programs include:

Palifosfamide (ZIO-201) is a potent bi-functional DNA alkylating agent that has activity in multiple tumors by evading typical resistance pathways. Palifosfamide is in the same class as bendamustine, cyclophosphamide, and ifosfamide. Intravenous palifosfamide is currently being studied in a randomized, double-blinded, placebo-controlled Phase 3 trial (PICASSO 3) for the treatment of first-line metastatic soft tissue sarcoma and is also in a pivotal Phase 3 trial (MATISSE) for first-line metastatic small cell lung cancer. Additionally, the Company is developing an oral capsule form of palifosfamide.

Ad-RTS IL-12 is currently being tested in a Phase 2 study. Ad-RTS IL-12 uses synthetic biology to enable controlled, local delivery of therapeutic interleukin-12 (IL-12), a protein important for an immune response to cancer. ZIOPHARM's DNA synthetic biology platform is being developed in partnership with Intrexon Corporation and employs an inducible gene-delivery system that enables controlled, local delivery of genes that produce therapeutic proteins to treat cancer. This is achieved by placing IL-12 under the control of Intrexon's proprietary biological "switch" (the RheoSwitch Therapeutic System(R), RTS(R)) to turn on/off the therapeutic protein expression at the tumor site.

Indibulin (ZIO-301) is a novel, tubulin binding agent that is expected to have several potential benefits, including oral dosing, application in multi-drug resistant tumors, no neuropathy and a tolerable toxicity profile. It is currently being studied in a Phase 1/2 trial in metastatic breast cancer.

The rest is here:
ZIOPHARM Oncology Presents Systemic, DNA/Cell Plasmid Therapy Showing Long-Term Persistence and Anti-Tumor Effects at ...

DuPont, CSHL Extend Plant Biology Research Alliance

Posted on by

The Institute of Medicine of the National Academy of Sciences has elected 70 new members including Lynda Chin, Stephen Quake, and Daniel Kastner. Chin is currently a professor and chair of genomic medicine and scientific director of the Institute for Applied Cancer Science at the University of Texas MD Anderson Cancer Center. Quake is a professor of bioengineering at Stanford University and an investigator at the Howard Hughes Medical Institute. Kastner is the scientific director of the National Human Genome Research Institute, where, among other duties, he leads the inflammatory disease section of the medical genetics branch.

Caprotec Bioanalytics has appointed Jonathan Turner to be CEO and managing director. Turner will take over the CEO spot from company founder Hubert Koester, who will continue to work with the company as acting chief scientific officer and chairman of the scientific advisory board. Turner formerly was senior VP at XL Techgroup, a technology developer and equity firm, and he held senior management posts at Boehringer Ingelheim, Astrazeneca, and Schering.

Bill Bowen has been appointed by Sequenom SVP and general counsel. He will report directly to Chairman and CEO Harry Hixson and will be responsible for the company's legal and patent issues. Bowen was previously with Gen-Probe, where he was SVP and general counsel. Before that he was a business litigation partner at Luce Forward Hamilton & Scripps.

View original post here:
DuPont, CSHL Extend Plant Biology Research Alliance

DuPont and Cold Spring Harbor Laboratory Extend Collaboration in Cutting-Edge Plant Biology Research for Another Five …

Posted on by

WILMINGTON, Del. & COLD SPRING HARBOR, N.Y.--(BUSINESS WIRE)--

DuPont and Cold Spring Harbor Laboratory (CSHL) today announced the renewal for another five years of a research collaboration that began in 2007. This multi-million dollar collaboration supports cutting-edge plant biology research focused on meeting growing food demands worldwide.

With the worlds population expected to grow by more than 2 billion by 2050, this collaboration will help make possible crucial improvements in plant breeding that will help increase yields from available acreage.

Innovative science and technology are at the core of productivity improvements that will allow us to meet global food security goals of ensuring that people everywhere have access to sufficient and nutritious food that meets their dietary need and food preferences for a healthy life, said DuPont Agricultural Biotechnology Vice President John Bedbrook. We must leverage all the science and technology tools available, including this important collaboration with CSHL. Our collaboration has contributed to and will continue to contribute to increasing our understanding of the basic genetic mechanisms controlling plant growth and development which will contribute to global food security in the coming decades.

CSHLs successful partnership with DuPont Pioneer has fostered strong collaboration between a uniquely aligned group of research and industry scientists, said CSHL President Bruce Stillman. These two groups are leveraging each others strengths to achieve research results that we believe will lead to important improvements in crop yield around the world.

CSHL and Pioneer are investing in discovery research that tackles some of the most fundamental aspects of plant biology. The renewal of the collaboration agreement will continue the expansion of knowledge about the genetic basis of fundamental plant processes controlling growth, development and yield. This collaboration will help facilitate the development of innovative products to meet future global food needs.

As scientists, we get excited about seeing our discoveries translated into real-world applications, said Rob Martienssen, a CSHL professor and Howard Hughes Medical Institute Investigator. It is clear that basic research in these areas has the potential to radically change the face of the agricultural industry.

Founded in 1890, Cold Spring Harbor Laboratory (CSHL) has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology. CSHL is ranked number one in the world by Thomson Reuters for impact of its research in molecular biology and genetics. The Laboratory has been home to eight Nobel Prize winners. Today, CSHL's multidisciplinary scientific community is more than 360 scientists strong and its Meetings & Courses program hosts more than 12,500 scientists from around the world each year to its Long Island campus and its China center. Tens of thousands more benefit from the research, reviews and ideas published in journals and books distributed internationally by CSHL Press. The Laboratory's education arm also includes a graduate school and programs for undergraduates as well as middle and high school students and teachers. CSHL is a private, not-for-profit institution on the north shore of Long Island. For more information, visit http://www.cshl.edu.

DuPont Pioneer is the worlds leading developer and supplier of advanced plant genetics, providing high-quality seeds to farmers in more than 90 countries. Pioneer provides agronomic support and services to help increase farmer productivity and profitability and strives to develop sustainable agricultural systems for people everywhere. Science with Service Delivering Success.

DuPont (DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders, we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com.

More here:
DuPont and Cold Spring Harbor Laboratory Extend Collaboration in Cutting-Edge Plant Biology Research for Another Five ...

Starch: Chemistry And Technology – Video

Posted on by


Starch: Chemistry And Technology
ll4.me Starch: Chemistry And Technology The third edition of this long-serving successful reference work is a #39;must-have #39; reference for anyone needing or desiring an understanding of the structure, chemistry, properties, production and uses of starches and their derivatives.* Includes specific information on corn, wheat, potato, rice, and new chapters on rye, oat and barley (including waxy barley) starches * Covers the isolation processes, properties, functionalities, and uses of the most commonly used starches. * Explores the genetics, biochemistry, and physical structure of starches * Presents current and emerging application trends for starch Publisher: Academic Press Illustration: N Language: ENG Title: Starch: Chemistry and Technology Pages: 00894 (Encrypted EPUB) / 00000 (Encrypted PDF) On Sale: 2009-03-27 SKU-13/ISBN: 9780127462752 Category: Technology Engineering : Food Science Category: Science : Chemistry - Organic Category: Science : Life Sciences - Biochemistry The third edition of this long-serving successful reference work is a #39;must-have #39; reference for anyone needing or desiring an understanding of the structure, chemistry, properties, production and uses technology, engineering, food science, science, chemistry, organicFrom:barrysmith568Views:0 0ratingsTime:00:16More inPeople Blogs

See the original post here:
Starch: Chemistry And Technology - Video

Garry Rumbles: NREL takes on challenges in the development of organic photovoltaics – Video

Posted on by


Garry Rumbles: NREL takes on challenges in the development of organic photovoltaics
As OPV efficiency improves, many mysteries still remain to be solved. spie.org - SPIE Optics + Photonics Conference. Garry Rumbles works in the Solar Photochemistry program for the United States Department of Energy, at the National Renewable Energy Lab (NREL) in Golden, Colorado. His research focuses on the basic science of solar photoconversion and photoinduced electron transfer processes in polymer-based nanostructured interfaces, and increasing understanding of how charges are generated in organic polymers. Work in organic photovoltaics over the last decade has progressed to an efficiency of more than 10%, Rumbles is a Research Fellow at NREL. He joined the lab in 2000 and is widely recognized for his research in photochemistry and photophysics of conjugated molecular systems, energy conversion in organic light emitting diodes and organic photovoltaic devices, and nanoscale morphology. He is a Professor Adjoint in the Department of Chemistry and Biochemistry at CU Boulder; and in 2009 he became a Fellow of the joint CU/NREL adventure: Renewable and Sustainable Energy Institute (RASEI). In 2004, he was made a Fellow of the Royal Society of Chemistry.From:SPIETVViews:12 0ratingsTime:05:23More inScience Technology

Originally posted here:
Garry Rumbles: NREL takes on challenges in the development of organic photovoltaics - Video

Peptide-lipid Interactions – Sidney A. Simon – Video

Posted on by


Peptide-lipid Interactions - Sidney A. Simon
ll4.me Peptide-lipid Interactions - Sidney A. Simon Peptides are involved in numerous biological processes that include: killing bacteria, signal transduction, cell growth, and synaptic transmission. This reference book presents an overview of the interaction of peptides with synthetic and biological membranes, and includes state-of-the-art methodology, computer simulations and theoretical analysis. This book contains numerous color figures and can be used by persons interested in cell biology, physical chemistry, nanotechnology, biochemistry , cell biology, and biophysics.Key Features* world-renowned experts* state-of-the-art experimental methods* monolayers, bilayers, biological membranes * theoretical aspects and computer simulations* rafts* synaptic transmission* membrane fusion* signal transduction Publisher: Academic Press Illustration: N Language: ENG Title: Peptide-Lipid Interactions Pages: 00583 (Encrypted PDF) On Sale: 2002-10-24 SKU-13/ISBN: 9780126438710 Category: Science : Life Sciences - Biophysics Peptides are involved in numerous biological processes that include: killing bacteria, signal transduction, cell growth, and synaptic transmission. This reference book presents an overview of the int sidney a. simon, science, life sciences, biochemistryFrom:melissacopeland173Views:0 0ratingsTime:00:13More inPeople Blogs

Read the original post:
Peptide-lipid Interactions - Sidney A. Simon - Video

Glycogenesis – Video

Posted on by


Glycogenesis
http://www.SalmonellaPlace.com This is a tutorial/lecture on Glycogenesis. We cover some topics important for classes such as Biochemistry, Molecular and Cellular Biology, Introductory Biology, etc. List of topics: - Steps of Glycogenesis; - Enzymes involved. If you have any questions, don #39;t be shy!! We hope we are able to clarify this topic. Enjoy!From:TheSalmonellaPlaceViews:17 2ratingsTime:04:46More inEducation

See more here:
Glycogenesis - Video

Rna Turnover In Bacteria, Archaea And Organelles – Video

Posted on by


Rna Turnover In Bacteria, Archaea And Organelles
ll4.me Rna Turnover In Bacteria, Archaea And Organelles Specific complexes of protein and RNA carry out many essential biological functions, including RNA processing, RNA turnover, RNA folding, as well as the translation of genetic information from mRNA into protein sequences. Messenger RNA (mRNA) decay is now emerging as an important control point and a major contributor to gene expression. Continuing identification of the protein factors and cofactors, and mRNA instability elements, responsible for mRNA decay allow researchers to build a comprehensive picture of the highly orchestrated processes involved in mRNA decay and its regulation.Covers the difference in processing of mRNA between eukaryotes, bacteria and archea. Benefit: Processing of mRNA differs greatly between eukaryotes, bacteria and archea and this affords researchers readily reproducible techniques to understand and study the molecular pathogenesis of disease.Expert researchers introduce the most advanced technologies and techniques to identify mRNA processing, transport, localization and turnover which are central to the process of gene expression. Benefit: Keeps MIE buyers and online subscribers up-to-date with the latest researchOffers step by step lab instructions including necessary equipment and reagents. Benefit: Provides tried and tested techniques which eliminate searching through many different sources. Tested techniques are trustworthy and avoid pitfalls so the same mistakes are not made over ...From:candaceharris347Views:0 0ratingsTime:00:15More inPeople Blogs

See the original post here:
Rna Turnover In Bacteria, Archaea And Organelles - Video

Brain Biochemistry: Using the TRIAD Panel to Treat Neurological Disorders – Video

Posted on by


Brain Biochemistry: Using the TRIAD Panel to Treat Neurological Disorders
In, "Brain Biochemistry: Using the Triad Panel to Treat Neurological Disorders," Cass Nelson-Dooley, MS, will describe the clinical conditions which can benefit from assessment with the Triad, reveal common brain biochemistry patterns that may be underlying neurological illness, and demonstrate how to build an effective nutritional and dietary treatment plan to improve patient outcomes. The Triad Profile is an important tool in any clinician #39;s toolbox when evaluating and treating a patient with neurological symptoms. http://www.metametrix.com http http://www.metametrixinstitute.orgFrom:metametrixViews:54 1ratingsTime:01:02:32More inScience Technology

The rest is here:
Brain Biochemistry: Using the TRIAD Panel to Treat Neurological Disorders - Video

Glycogen Storage Diseases – Video

Posted on by


Glycogen Storage Diseases
http://www.SalmonellaPlace.com This is a tutorial/lecture on Glycogen Storage Diseases. We cover some topics important for classes such as Biochemistry, Molecular and Cellular Biology, Introductory Biology, etc. If you have any questions, don #39;t be shy!! We hope we are able to clarify this topic. Enjoy!From:TheSalmonellaPlaceViews:0 0ratingsTime:03:18More inEducation

Read more from the original source:
Glycogen Storage Diseases - Video